List of Asana Biosciences patents

List of Asana Biosciences patents

List of Wistron Corporation patents

List of Molecule Works Inc. patents

List of Idealab patents

List of funding rounds for Luoji Siwei

List of funding rounds for Bambuser

Patents where

Current Assignee

Name

is

‌

Asana Biosciences

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 10471051 Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancer	Patent 10471051 was granted and assigned to Asana Biosciences on November, 2019 by the United States Patent and Trademark Office.	‌ Asana Biosciences	‌ Asana Biosciences		United States Patent and Trademark Office	10471051	November 12, 2019
	‌ US Patent 11103491 Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancer	Patent 11103491 was granted and assigned to Asana Biosciences on August, 2021 by the United States Patent and Trademark Office.	‌ Asana Biosciences	‌ Asana Biosciences		United States Patent and Trademark Office	11103491	August 31, 2021
	‌ US Patent 11339169 P2X	Patent 11339169 was granted and assigned to Asana Biosciences on May, 2022 by the United States Patent and Trademark Office.	‌ Asana Biosciences	‌ Asana Biosciences		United States Patent and Trademark Office	11339169	May 24, 2022
	‌ US Patent 10174039 P2X	Patent 10174039 was granted and assigned to Asana Biosciences on January, 2019 by the United States Patent and Trademark Office.	‌ Asana Biosciences	‌ Asana Biosciences		United States Patent and Trademark Office	10174039	January 8, 2019
	‌ US Patent 11434278 Protein-polymer-drug conjugates	Patent 11434278 was granted and assigned to Asana Biosciences on September, 2022 by the United States Patent and Trademark Office.	‌ Asana Biosciences	‌ Asana Biosciences		United States Patent and Trademark Office	11434278	September 6, 2022
	‌ US Patent 10226468 Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathways	Patent 10226468 was granted and assigned to Asana Biosciences on March, 2019 by the United States Patent and Trademark Office.	‌ Asana Biosciences	‌ Asana Biosciences		United States Patent and Trademark Office	10226468	March 12, 2019
	‌ US Patent 10316039 P2X	Patent 10316039 was granted and assigned to Asana Biosciences on June, 2019 by the United States Patent and Trademark Office.	‌ Asana Biosciences	‌ Asana Biosciences		United States Patent and Trademark Office	10316039	June 11, 2019
	‌ US Patent 10544145 P2X	Patent 10544145 was granted and assigned to Asana Biosciences on January, 2020 by the United States Patent and Trademark Office.	‌ Asana Biosciences	‌ Asana Biosciences		United States Patent and Trademark Office	10544145	January 28, 2020
	‌ US Patent 10188654 Uses of pyrimido-pyridazinones to treat cancer	Patent 10188654 was granted and assigned to Asana Biosciences on January, 2019 by the United States Patent and Trademark Office.	‌ Asana Biosciences	‌ Asana Biosciences		United States Patent and Trademark Office	10188654	January 29, 2019
	‌ US Patent 10316080 Protein-polymer-drug conjugates	Patent 10316080 was granted and assigned to Asana Biosciences on June, 2019 by the United States Patent and Trademark Office.	‌ Asana Biosciences, Llc	‌ Asana Biosciences		United States Patent and Trademark Office	10316080	June 11, 2019
	‌ US Patent 10912779 Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathways	Patent 10912779 was granted and assigned to Asana Biosciences on February, 2021 by the United States Patent and Trademark Office.	‌ Asana Biosciences	‌ Asana Biosciences		United States Patent and Trademark Office	10912779	February 9, 2021
	‌ US Patent 9757382 Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathways	Patent 9757382 was granted and assigned to Asana Biosciences on September, 2017 by the United States Patent and Trademark Office.	‌ Asana Biosciences	‌ Asana Biosciences		United States Patent and Trademark Office	9757382	September 12, 2017
	‌ US Patent 10695296 Formulations, methods, kit, and dosage forms for improved stability of an active pharmaceutical ingredient		‌ Asana Biosciences	‌ Asana Biosciences		United States Patent and Trademark Office	10695296	June 30, 2020
	‌ US Patent 10611768 P2X	Patent 10611768 was granted and assigned to Asana Biosciences on April, 2020 by the United States Patent and Trademark Office.	‌ Asana Biosciences	‌ Asana Biosciences		United States Patent and Trademark Office	10611768	April 7, 2020
	‌ US Patent 10869872 Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathways		‌ Asana Biosciences	‌ Asana Biosciences		United States Patent and Trademark Office	10869872	December 22, 2020
	‌ US Patent 10590127 P2X	Patent 10590127 was granted and assigned to Asana Biosciences on March, 2020 by the United States Patent and Trademark Office.	‌ Asana Biosciences	‌ Asana Biosciences		United States Patent and Trademark Office	10590127	March 17, 2020
	‌ US Patent 10751332 Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancer	Patent 10751332 was granted and assigned to Asana Biosciences on August, 2020 by the United States Patent and Trademark Office.	‌ Asana Biosciences, Llc	‌ Asana Biosciences		United States Patent and Trademark Office	10751332	August 25, 2020
	‌ US Patent 10183944 Pyrimido-pyridazinone compounds and methods of use thereof	Patent 10183944 was granted and assigned to Asana Biosciences on January, 2019 by the United States Patent and Trademark Office.	‌ Asana Biosciences, Llc	‌ Asana Biosciences		United States Patent and Trademark Office	10183944	January 22, 2019

18 results

0 selected

18 results

0 selected